Action in Diabetes and Vascular disease: preterAx and diamicroN-mr Controlled Evaluation

Trial Profile

Action in Diabetes and Vascular disease: preterAx and diamicroN-mr Controlled Evaluation

Not stated
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2006

At a glance

  • Drugs Perindopril/indapamide (Primary) ; Antihyperglycaemics; Antihypertensives; Gliclazide
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms ADEPT
  • Most Recent Events

    • 29 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top